Andrew Stewart Plump

President, R&D at Takeda Pharmaceutical Company Limited

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
8 months
Director since
2026

8 months of board service in total across 1 board, counting each seat separately. Longest: Takeda Pharmaceutical Company Limited, 8 months.

Takeda Pharmaceutical Company Limited Director · President, R&D
8 months · Since 2026

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 2, 2026 Takeda Pharmaceutical Company Limited Open-market sale −116,191 $18.49 $2,148,372
Aug 19, 2026 Takeda Pharmaceutical Company Limited Open-market sale −19,651 $18.49 $363,347
Aug 10, 2026 Takeda Pharmaceutical Company Limited Open-market sale −165,393 $17.10 $2,828,220
Jul 1, 2026 Takeda Pharmaceutical Company Limited Grant or award +125,390 — —
Apr 27, 2026 Takeda Pharmaceutical Company Limited Grant or award +212,470 — —

Questions about Andrew Stewart Plump

What boards is Andrew Stewart Plump on?

Andrew Stewart Plump sits on the board of Takeda Pharmaceutical Company Limited.

How long has Andrew Stewart Plump served on boards?

Our records show at least 8 months of board service across 1 board, the earliest from 2026.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.